Stocks to Watch: VIASPACE Inc. (OTCBB: VSPC), Genta Incorporated (Nasdaq: GNTA), Micromem Technologies Inc. (OTC BB:MMTIF), Argyle Security Acquisition Corporation (OTC BB:ARGL) , XsunX, Inc (OTCBB: XSNX)
Featured Stock: VIASPACE Inc.
(OTCBB: VSPC)
Current Price (0.03)
VIASPACE CEO OUTLINES THE BILLION DOLLAR PROFIT POTENTIAL FOR FUEL CELL CARTRIDGES
PASADENA, CA — May 28, 2008—VIASPACE Inc. (OTCBB: VSPC) today provided a brief overview of both fuel cells as well as the business model for fuel cell cartridges which VIASPACE’s subsidiary, Direct Methanol Fuel Cell Corporation (“DMFCC”), is pursuing. VIASPACE and DMFCC CEO, Dr. Carl Kukkonen, states, “Fuel cartridges are the consumable in the fuel cell business. Fuel cells are like a razor with fuel cartridges as the razor blades. VIASPACE and DMFCC are helping to build a new industry that, while it does not exist today, has the potential to produce tens of billions of dollars in revenue over the next five years. “
“If the large portable electronic OEMs are successful in developing fuel cell powered portable electronics, five to 10 billion cartridges per year could be sold with potential profits exceeding $1 billion per year. There are plenty of risks, but the potential profits are huge.”
An overview of both fuel cells and the cartridges business model is outlined below.
1. Fuel cells are electrochemical engines that produce electricity directly from the fuel without burning. Electricity is made very efficiently and fuel cells are a green technology
2. The first market for fuel cells is likely to be in portable electronics. Compared to batteries, fuel cells enable a longer device operating time in addition to instant recharging, by replacing the disposable fuel cartridge without the need for an electrical plug and several hours to recharge. The convenience and increased productivity of new power-hungry portable electronic devices such as smart phones currently drives the market.
3. Direct methanol fuel cells seem to represent the fuel cell of choice by most portable electronics manufacturers. Samsung, Sony, Toshiba, Hitachi, Panasonic and other large OEMs have already demonstrated that notebook computers, mobile phones and other devices can be powered by direct methanol fuel cells. In fact, we believe that they are spending hundreds of millions of dollars to develop fuel cells and the products that use them.
4. International safety regulations developed by Underwriters Laboratories and the Japanese Electric Manufacturers Association have specified that a fuel must be contained in a safe, sealed and preferably disposable container called a cartridge. DMFCC is a member of these international committees.
5. With these safety regulations, the International Civil Aviation Organization and the US Department of Transportation have recently allowed direct methanol fuel cells and cartridges to be carried on airplanes by passengers and aircrew. This is a major breakthrough.
6. According to industry sources, there were 100 million notebook computers and 1.1 billion mobile phones produced worldwide in 2007, and these figures are projected to rise to 160 million notebooks and 1.8 billion mobile phones in about five years. If the OEMs succeed in their product offerings, it is projected that up to 22% of notebook computers and 2.5% of mobile phones will be powered by fuel cells in about five years. This leads to a projection of 91 million fuel cell powered devices sold. Independently, Frost and Sullivan have projected that 71 million fuel cell powered portable electronic devices will likely be sold in 2011. OEMs are currently spending hundreds of millions of dollars to try and capture this large new market.
7. Each notebook computer and mobile phone powered by a fuel cell is projected to use between two and four cartridges per month over its three-year lifetime. If the OEMs are successful, this level of cartridge usage amounts to five to 10 billion cartridges per year, approximately five years from introduction. This is the market that DMFCC is pursuing.
8. While specific cartridge pricing has not yet been determined, cartridges are projected to sell for between $3.00 and $5.00 each, and the overall cartridge industry could be worth as much as $15 billion to $30 billion per year at the retail level. Consequently, cartridge manufacturing and distribution profits could be in the billions of dollars per year. That is why DMFCC is in the cartridge business.
9. DMFCC has an established global network of qualified cartridge manufacturing partners that are already trusted suppliers to many OEMs. DMFCC is already working with Samsung and other companies on cartridges.
10. The OEMs want to sell notebook computers and mobile phones and, while most do not want to manufacture and sell cartridges, they do want cartridges to be widely available. DMFCC's investment cost in the cartridge business is much lower than the costs being expended by OEMs on developing the fuel cells. DMFCC’s manufacturing partners are also sharing in the cartridge development costs.
11. In addition to providing cartridges, DMFCC also has the patents on direct methanol fuel cells that most OEMs will need to bring their DMFC products to market. DMFCC has stated that they are willing to provide this patent protection to the OEMs in exchange for a cartridge supply agreement. This is another incentive for OEMs to work directly with DMFCC.
12. DMFCC is, nonetheless, dependent on the OEMs’ success in bringing fuel cell powered portable electronics to the marketplace. In order to benefit from their success, DMFCC must be willing to take these risks together with the OEMs.
About VIASPACE: Originally founded in 1998 with the objective of transforming proven space and defense technologies from NASA and the Department of Defense into hardware and software solutions that solve today's complex problems, VIASPACE benefits from important patent and software licenses from Caltech, which manages NASA’s Jet Propulsion Laboratory. For more information, please visit our website at www.VIASPACE.com, or contact for Investor Relations, Dr. Jan Vandersande, Director of Communications at 800-517-8050, or IR@VIASPACE.com.
Press contact: Carl Kukkonen 626-768-3360
-----------------------------
This news release includes forward-looking statements. These forward-looking statements relate to future events or our future performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Such factors include the risks outlined in our periodic filings with the U.S. Securities and Exchange Commission, including our Annual Report on Form 10-KSB, for the fiscal year ended December 31, 2007, as well as general economic and business conditions, the ability to acquire and develop specific projects and technologies, the ability to fund operations, changes in consumer and business consumption habits, and other factors over which VIASPACE has little or no control.
For an in-depth analyst report, please visit : www.WallStreetStockReview.com
Genta Incorporated
(Nasdaq: GNTA)
Current Price (0.35)
www.WallStreetStockReview.com
BERKELEY HEIGHTS, N.J., May 30 - Genta Incorporated (OTC Bulletin Board: GNTA - News) announced preliminary results that have shown a high objective response rate in a pilot study that incorporates the Company's lead oncology product, Genasense® (oblimersen sodium) Injection, in a chemotherapy program for patients with advanced melanoma. In this study, Genasense was used to potentially enhance the clinical activity of temozolomide (Temodar®; Schering Plough, Inc.), the most commonly used anticancer drug for melanoma, combined with Abraxane® (paclitaxel protein-bound particles for injectable suspension; Abraxis Bioscience, Inc.). The data will be featured in a presentation at the annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago on June 1, 2008. Genta Incorporated engages in the identification, development, and commercialization of drugs for the treatment of cancer and related diseases in the United States. The company’s research portfolio consists of two major programs: DNA/RNA Medicines and Small Molecules. The DNA/RNA Medicines program includes drugs that are based on using modifications of either DNA or RNA as drugs that can be used to treat disease. This program includes technologies, such as antisense, decoys, aptamers, and small interfering or micro RNA. Its product Genasense, designed to block the production of a protein known as Bcl-2, which is used for the treatment of malignant melanoma, chronic lymphocytic leukemia, multiple myeloma, acute myelocytic leukemia, nonsmall-cell lung cancer, prostate cancer, small-cell lung cancer, breast cancer, colorectal cancer, nonHodgkin’s lymphoma, kidney cancer, pancreatic cancer, Waldenstrom’s macroglobulinemia, hepatocellular carcinoma, and childhood solid tumors. The Small Molecules program includes drugs that are based on gallium-containing compounds. Its product Ganite, a phase II product that is used as a treatment for cancer-related hypercalcemia that is resistant to hydration used primarily for patients with malignant lymphoma, bladder cancer, nonHodgkin’s lymphoma, and other cancer types. Genta was founded in 1988 and is based in Berkeley Heights, New Jersey.
Micromem Technologies Inc.
(OTC BB:MMTIF)
Current Price (1.74)
www.WallStreetStockReview.com
TORONTO, May 30 - Micromem Technologies Inc. (OTC BB: MMTIF - News; "Micromem" or the "Company") announces that its Board of Directors has adopted a shareholder rights plan (the "Rights Plan"). The Rights Plan, which took effect May 29, 2008, has been adopted to ensure the fair treatment of shareholders in the event of any take-over offer for the Company's common shares. Micromem Technologies, Inc. (www.micromeminc.com) is focused on the development of magnetic random access memory (MRAM) technology. We believe that once fully developed, this technology will be suitable for various applications including, without limitation, Radio Frequency Identification (RFID). It is anticipated that RFID will be Micromem's first market objective. Micromem's primary technology was developed pursuant to an exclusive world wide commercial license issued by the University of Toronto ("UT"). Pursuant to the terms of the license, Micromem can buy out the balance of its financial obligations with respect to the patents and technology licensed by UT for a fixed fee. The MRAM development work was undertaken in accordance with research collaboration agreements among Micromem, the University of Toronto, Dr. Harry Ruda and OCE Inc., a not-for-profit corporation supported through the Ontario Ministry of Economic Development and Trade's (MEDT) Ontario Centres of Excellence program.
Argyle Security Acquisition Corporation
(OTC BB:ARGL)
Current Price (6.15)
www.WallStreetStockReview.com
SAN ANTONIO--May 30--Argyle Security, Inc., (OTC BB:ARGL - News), (“Argyle”) a service and solutions provider in the physical electronic security industry, announced today that it is scheduled to present at RedChip’s upcoming Small Cap Investor Conference on Thursday, June 5, 2008 at 3 P.M. Pacific Time. The event will be held at the Palace Hotel in San Francisco, California. Argyle Security was established as a special purpose acquisition corporation with the objective of effecting a merger, capital stock exchange, asset acquisition or other business combination with an unidentified operating business in the security industry. Argyle Security's goal is to become a leading global company that provides solutions for the physical electronic security industry. Its channel focus will be Video Surveillance, Access Control, Perimeter/Outdoor Protection, Intrusion Protection, Fire Detection and Threat Analysis, serving selected commercial, governmental and residential markets. Argyle Security was co-founded by Messrs. Marbut and Chaimovski. In addition to Messrs. Marbut and Chaimovski, Argyle's founding Board of Directors includes Gen. Wesley K. Clark and Mr. John J. (Chip) Smith.
XsunX, Inc
(OTCBB: XSNX)
Current Price (0.44)
www.WallStreetStockReview.com
ALISO VIEJO, Calif., May 28 -- XsunX, Inc. (OTC Bulletin Board: XSNX - News), a solar technology company engaged in the build-out of its multi-megawatt solar module manufacturing facility, announced today that it has expanded its existing two-year relationship with Newport Corporation (Nasdaq: NEWP - News) by selecting Newport as its preferred supplier for laser and motion subsystems for its integrated Thin Film Photovoltaic (PV) manufacturing line. These products are used to create monolithically interconnected cells on the solar panels and to laser scribe bar codes on the panels for quality control purposes. XsunX, Inc. engages in the development, commercialization, and licensing of proprietary solar cell designs and core solar cell manufacturing systems. The company’s designs and manufacturing systems enables licensees to manufacture advanced thin film solar devices on various substrates. It focuses on two primary solar cell device types for production that include Power Glass, for semi-transparent and opaque applications on both flexible and rigid substrates; and Hybrid 4-Terminal, for opaque applications rivaling silicon wafer efficiencies. The company primarily serves original equipment manufacturers in the thin film solar products market. It has a strategic alliance with MVSystems, Inc. The company, formerly known as Sun River Mining, Inc., was incorporated in 1997 and changed its name to XsunX, Inc. in 2003. XsunX is based in Aliso Viejo, California.
WallStreetStockReview.com is owned and operated by Iron Consulting LLC
Verify all claims and do your own due diligence. Iron Consulting profiles are not a solicitation or recommendation to buy, sell or hold securities. Iron Consulting is not offering securities for sale. An offer to buy or sell can be made only with accompanying disclosure documents and only in the states and provinces for which they are approved. All statements and expressions are the sole opinion of the editor and are subject to change without notice. Iron Consulting is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. It should be understood there is no guarantee that past performance will be indicative of future results. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. In order to be in full compliance with the Securities Act of 1933, Section 17(b), WallStreetStockReview.com is owned and operated by Iron Consulting. Iron Consulting www.ironconsultinginc.com has previously been paid two hundred and twenty three thousand dollars from Equity Alliance Intl. for a one year three month program and a additional ninety five thousand for current six month coverage starting March 1, 2008, from Equity Alliance Int. LLC www.equityallianceir.com for its marketing and consulting services. Neither Iron Consulting nor any of its affiliates, or employees shall be liable to you or anyone else for any loss or damages from use of this e-mail, caused in whole or part by its negligence or contingencies beyond its control in procuring, compiling, interpreting, reporting, or delivering this Web Site or e-mail and any contents. Since Iron Consulting receives compensation and its employees or members of their families may hold stock in the profiled companies, there is an inherent conflict of interest in Iron Consulting statements and opinions and such statements and opinions cannot be considered independent. Iron Consulting and its management may benefit from any increase in the share prices of the profiled companies. Information contained herein contains "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities and Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be "forward looking statements". Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Iron Consulting services are often paid for using free-trading shares. Iron Consulting may be selling shares of stock at the same time the profile is being disseminated to potential investors; this should be viewed as a definite conflict of interest and as such, the reader should take this into consideration.
